The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
Elina Eleftheria PliakosPanayiotis D ZiakasEleftherios MylonakisPublished in: Open forum infectious diseases (2021)
The use of cefazolin is a cost-effective strategy for the treatment of MSSA bacteremia and, when clinically appropriate, this strategy results in considerable health care cost-savings.